ResMed Logo

Type 2 diabetes

Sleep apnoea is common among patients with type 2 diabetes.1 It is independently associated with insulin resistance, glucose intolerance and metabolic syndrome,2-4 and when untreated, can lead to poor overall treatment outcomes.

However, despite the number of type 2 diabetes patients with SDB, it largely goes undiagnosed.

 

Screen your patients for type 2 diabetes and SDB

 

As a result of accumulated research, the International Diabetes Federation recognises the association between type 2 diabetes and sleep apnoea, and recommends routinely screening OSA patients for type 2 diabetes, and screening type 2 diabetes patients displaying sleep apnoea symptoms for OSA.

And because patients with sleep apnoea and patients with diabetes share similar comorbidities, screening both ways is recommended: check for sleep apnoea in diabetes patients, and check for diabetes in patients with sleep apnoea.5

Use these helpful sleep and diagnosis resources to get your patients screened for SDB.

More SDB and chronic diseases

Sleep apnoea and cardiovascular disease (CVD)
ResMed explains the various cardiovascular diseases (CVD) associated with sleep apnoea: hyptension, coronary artery disease, cardiac rhythm disorders, heart failure, stroke.
Chronic obstructive pulmonary disease (COPD)
Sleep apnoea and Chronic obstructive pulmonary disease (COPD) often coexist in sleep-disordered breathing (SDB) patients. Learn more about the relationship linking COPD to sleep apnoea.

References

  1. Einhorn et al. Endocr Pract. 2007
  2. Aronsohn et al. Am J Respir Crit Care Med. 2010
  • 3: Punjabi et al. Am J Respir Crit Care Med. 2002
  • 4: Coughlin et al. Eur Heart J. 2004
  • 5: International Diabetes Federation. The IDF consensus statement on sleep apnoea and type 2 diabetes. Brussels, Belgium: International Diabetes Federation; 2008